Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide-Reference-Cited by-同舟云学术

Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide

Published:2022-01 Issue:2 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Poosti Fariba¹,Soebadi Mohammad Ayodhia²³,Crijns Helena¹^ORCID,De Zutter Alexandra¹^ORCID,Metzemaekers Mieke¹,Berghmans Nele¹,Vanheule Vincent¹,Albersen Maarten²,Opdenakker Ghislain⁴,Van Damme Jo¹,Sprangers Ben¹⁵,Proost Paul¹^ORCID,Struyf Sofie¹^ORCID

Affiliation:

1. Laboratory of Molecular Immunology Department of Microbiology, Immunology and Transplantation Rega Institute KU Leuven Leuven Belgium

2. Laboratory of Experimental Urology University Hospitals Leuven Leuven Belgium

3. Department of Urology Faculty of Medicine Universitas Airlangga Surabaya Indonesia

4. Laboratory of Immunobiology Department of Microbiology, Immunology and Transplantation Rega Institute KU Leuven Leuven Belgium

5. Department of Nephrology University Hospitals Leuven Leuven Belgium

Funder

Fonds Wetenschappelijk Onderzoek

KU Leuven

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1370

Reference60 articles.

1. Renal fibrosis: New insights into the pathogenesis and therapeutics

2. Mechanistic connection between inflammation and fibrosis

3. Inflammation and fibrosis

4. Chemokines and chemokine receptors: Update on utility and challenges for the clinician

5. Chemokines

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways;Biomolecules;2023-07-28

2. Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects;Biomedicine & Pharmacotherapy;2023-01